Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sahely chemicals pty. ltd. - formaldehyde - liquid - formaldehyde aldehyde active 400.0 g/l - disinfectant - hatchery | incubator | poultry farm | poultry sheds on broiler/breeder farm | setters | egg incubator | poultry hatcheries - general disinfection | antiviral agent | aviaries | catteries | detergent | feeding utensils | flesh wounds | floor | germicidal detergent | kennel | mastitis | mould growth | poultry cages | protozoans | stables | toilets (not septic) | walls

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sahely chemicals pty. ltd. - benzalkonium chloride - aqueous concentrate - benzalkonium chloride ammonium-quaternary active 110.0 g/l - sanitiser - animal housing | dairy or milking shed | food preparation and/or storage area | general disinfection-pigpen | poultry shed | bak - general disinfection | antiviral agent | aviaries | catteries | detergent | feeding utensils | flesh wounds | floor | germicidal detergent | kennel | mastitis | mould growth | poultry cages | protozoans | stables | toilets (not septic) | walls

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - picloram present as the potassium salt; mcpa present as the potassium salt - soluble concentrate - picloram present as the potassium salt anilide/aniline-pyrimidine active 26.0 g/l; mcpa present as the potassium salt phenoxy acids-mcpa active 420.0 g/l - herbicide - barley | canary grass | linola | linseed crop | oats | triticale | wheat | early tillering - capeweed | climbing buckwheat | dock | mustard | new zealand spinach | saffron thistle | skeleton weed | sorrel | sowthistles | three cornered jack or doublegee | turnip weed | variegated thistle | wild mustard - seed | wild radish or radish weed | wild turnip | wireweed, knotweed or hogweed | acetosella vulgaris | blessed thistle | brassica campestris | brassica rapa ssp. sylvestris | brassica rapa var. sylvestris | broadleaf dock | bull thistle | cabbage thistle | carduus marianus | corn sowthistle | curled dock | fallopia aviculare | false star thistle | giant mustard | holy thistle | jointed charlock | lady's thistle | milk thistle | native spinach | perennial sow thistle | radish (wild) | raphanus rugosum | rapistrum weed | red sorrel | rumex brownii | rumex crispus | rumex obtusifolius | sheep sorrel | sheep's sorrel | short-fruited turnip | short-fruited wild turnip | sisymbrium officinale | sisymbrium orientale | sonchus arvensis | sonchus asper | sonchus oleraceus | sour dock | sow thistles | spiny e

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - deltamethrin - topical solution/suspension - deltamethrin pyrethroid active 15.0 g/l - parasiticides - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - buffalo fly | stable fly

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ecolab pty ltd - nitric acid; phosphoric acid - aqueous concentrate - nitric acid acid-general active 295.0 g/l; phosphoric acid mineral-phosphorus-acid active 162.0 g/l - dairy cleanser - milking equipment | milking machine - bacterial prevention, cleansing or disin | disinfecting

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - bifenthrin - suspension concentrate - bifenthrin pyrethroid active 100.0 g/l - insecticide - bowling green | carnation | domestic building/structure - external a | domestic building/structure-internal | home garden lawn o - african black beetle | ant | aphid | argentine stem weevil | bill bug | biting midge | black or black house ant | caterpillar | coastal brown ant | cockroach | corn earworm | cutworm - agrotis spp. | flea | fly | funnel ant | geranium plume moth | helicoverpa spp. | lawn armyworm | light brown apple moth | looper | mealy bug | mosquito | native budworm or bollworm | paper nest wasp | plague thrips | poinsettia whitefly | spider | stinging ant | sugar ant | tick | two spotted mite | whitefly | adult mosquitoes | argentine ant | banded sugar ant | billbug | budworm | corn earworm | cotton bollworm | cotton whitefly | ctenocephalides spp. | grass grub | ground fleas | heliothis | la plata weevil | large cockroach | lawn caterpillar | looper | looper caterpillars | madeira ant | mealybug | native bollworm | native budworm | ochetellus glaber | papernest wasps | pharaoh ant | red spider mite | silverleaf whitefly | small cockroach | spider mite | tobacco budworm | tomato grub | two-spotted mite | two-spotted spide

United States - English - NLM (National Library of Medicine)

protein sciences corporation - influenza a virus a/michigan/45/2015 (h1n1) recombinant hemagglutinin antigen (unii: 69h0yj871t) (influenza a virus a/michigan/45/2015 (h1n1) recombinant hemagglutinin antigen - unii:69h0yj871t) - influenza a virus a/michigan/45/2015 (h1n1) recombinant hemagglutinin antigen 45 ug in 0.5 ml

United States - English - NLM (National Library of Medicine)

protein sciences corporation - influenza a virus a/michigan/45/2015 (h1n1) recombinant hemagglutinin antigen (unii: 69h0yj871t) (influenza a virus a/michigan/45/2015 (h1n1) recombinant hemagglutinin antigen - unii:69h0yj871t), influenza a virus a/hong kong/4801/2014 (h3n2) recombinant hemagglutinin antigen (unii: 2i1eol437m) (influenza a virus a/hong kong/4801/2014 (h3n2) recombinant hemagglutinin antigen - unii:2i1eol437m), influenza b virus b/brisbane/60/2008 recombinant hemagglutinin antigen (unii: 058u2312cr) (influenza b virus b/bri - influenza a virus a/michigan/45/2015 (h1n1) recombinant hemagglutinin antigen 45 ug in 0.5 ml - flublok is a vaccine indicated for active immunization against disease caused by influenza a virus subtypes and influenza type b virus contained in the vaccine. flublok is approved for use in persons 18 years of age and older. flublok is contraindicated in individuals with known severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine (see postmarketing experience [6.2] and description [11] ). pregnancy outcomes in women who have been exposed to flublok during pregnancy are being monitored. contact: protein sciences corporation by calling 1-888-855-7871. all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies are 2% to 4% and 15% to 20%, respectively. available data on flublok administered to pregnant women are insufficient to inform vaccine-associated risks in pregnant women. a developmental study of flublok has been performed in

United States - English - NLM (National Library of Medicine)

protein sciences corporation - influenza a virus a/california/7/2009 (h1n1) recombinant hemagglutinin antigen (unii: 1se9z7d2qr) (influenza a virus a/california/7/2009 (h1n1) recombinant hemagglutinin antigen - unii:1se9z7d2qr), influenza a virus a/texas/50/2012 (h3n2) recombinant hemagglutinin antigen (unii: 1iqz1wce3y) (influenza a virus a/texas/50/2012 (h3n2) recombinant hemagglutinin antigen - unii:1iqz1wce3y), influenza b virus b/massachusetts/2/2012 recombinant hemagglutinin antigen (unii: ayr0wzx7jh) (influenza b virus b/massachus - flublok is a vaccine indicated for active immunization against disease caused by influenza virus subtypes a and type b contained in the vaccine. flublok is approved for use in persons 18 years of age and older. in persons 18 through 49 years of age, this indication is based on a controlled clinical study demonstrating a decrease in influenza disease after vaccination with flublok. in persons 50 years of age and older, this indication is based on the immune response elicited by flublok; data demonstrating a decrease in influenza disease in persons 50 years and older after vaccination with flublok are not available. (see clinical studies [ 14]) flublok is contraindicated in individuals with known severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine (see description [11] and postmarketing experience [6.2]). reproduction studies have been performed in rats at a dose approximately 300 times the human dose (on a mg/kg basis) and have revealed no evidence of impaired fertility or harm to

United States - English - NLM (National Library of Medicine)

protein sciences corporation - influenza a virus a/california/7/2009 (h1n1) recombinant hemagglutinin antigen (unii: 1se9z7d2qr) (influenza a virus a/california/7/2009 (h1n1) recombinant hemagglutinin antigen - unii:1se9z7d2qr), influenza a virus a/switzerland/9715293/2013 (h3n2) recombinant hemagglutinin antigen (unii: d2053d6yqu) (influenza a virus a/switzerland/9715293/2013 (h3n2) recombinant hemagglutinin antigen - unii:d2053d6yqu), influenza b virus b/phuket/3073/2013 recombinant hemagglutinin antigen (unii: poq8dqo9s3) (influenza b - flublok is a vaccine indicated for active immunization against disease caused by influenza virus subtypes a and type b contained in the vaccine. flublok is approved for use in persons 18 years of age and older. in persons 18 through 49 years of age, this indication is based on a controlled clinical study demonstrating a decrease in influenza disease after vaccination with flublok. in persons 50 years of age and older, this indication is based on the immune response elicited by flublok; data demonstrating a decrease in influenza disease in persons 50 years and older after vaccination with flublok are not available. (see clinical studies [ 14] ) flublok is contraindicated in individuals with known severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine (see description [11] and postmarketing experience [6.2] ). reproduction studies have been performed in rats at a dose approximately 300 times the human dose (on a mg/kg basis) and have revealed no evidence of impaired fertility or harm t